Shankar Balasubramanian

Shankar Balasubramanian General Information

Biography

Mr. Shankar Balasubramanian is a Founding Partner of Ahren Innovation Capital. He is the founder of two companies and the principal inventor of the leading next-generation human genome sequencing technology core to all Illumina sequencing platforms, estimated to be worth >$30BN. This technology has made routine, accurate, low-cost sequencing of human genomes a reality, has revolutionized biology, and accelerated the development of genomic personalised medicine. He is the Herchel Smith Professor of Medicinal Chemistry at the University of Cambridge and Senior Group Leader at the Cancer Research UK Cambridge Institute. His awards include the Royal Medal (2018), the Royal Society Mullard Award (2009), The BBSRC Innovator of the year (2010), and the Tetrahedron Prize (2013). He is a Fellow of The Royal Society, the Academy of Medical Sciences, and a member of EMBO.